Since the implementation of the Medicinal Cannabis Scheme in April 2020, New Zealand has taken significant strides in making medicinal cannabis accessible to patients who need it most.
The medicinal cannabis scheme
The Scheme’s primary goal is to improve access to quality medicinal cannabis products for patients. It establishes strict minimum quality standards that all products—whether imported or domestically produced—must meet. This ensures that patients receive products that are safe, consistent, and free from harmful contaminants.
Access for patients
In New Zealand, medicinal cannabis is a prescription-only medicine. Patients cannot purchase it over the counter but must consult with a registered medical practitioner—such as a GP or specialist.
- ConsultationA doctor assesses the patient's condition and history to determine suitability.
- PrescriptionIf appropriate, a prescription is issued for a specific product tailored to the needs.
- DispensingThe product is dispensed via a pharmacy, ensuring full regulatory oversight.
Common conditions prescribed for include chronic pain, anxiety, and sleep disorders, though the decision always rests with the medical professional.
Quality & safety
One of the most critical aspects of the NZ regime is the focus on GMP (Good Manufacturing Practice). At Aho Farms, we adhere to these rigorous standards. Unlike the illicit market, medicinal cannabis products in NZ are tested for:
- Microbial contamination
- Heavy metals
- Pesticides
- Accurate cannabinoid content
Looking ahead
As the industry matures, we expect to see more New Zealand-grown products entering the market, potentially lowering costs and increasing variety for patients. Aho Farms is proud to be part of this future, cultivating premium flower right here in Hawke's Bay.